近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Eakins R, Walsh J, Randle L, Jenkins RE, Schuppe-Koistinen I, Rowe C, Lewis PS, Vasieva O, Prats N, Brillant N, Auli M, Bayliss M, Webb S, Rees JA, Kitteringham NR, Goldring CE, Park BK. 2015. Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome SCIENTIFIC REPORTS, 5 >DOI >Link
Stachulski AV, Baillie TA, Kevin Park B, Scott Obach R, Dalvie DK, Williams DP, Srivastava A, Regan SL, Antoine DJ, Goldring CEP, Chia AJL, Kitteringham NR, Randle LE, Callan H, Castrejon JL, Farrell J, Naisbitt DJ, Lennard MS. 2013. The generation, detection, and effects of reactive drug metabolites Medicinal Research Reviews, 33 :985-1080 >DOI
Goldring CE, Kitteringham NR, Elsby R, Randle LE, Clement YN, Williams DP, McMahon M, Hayes JD, Itoh K, Yamamoto M, Park BK. 2004. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice Hepatology, 39 :1267-1276 >Link
Eakins R, Walsh J, Randle L, Jenkins RE, Schuppe-Koistinen I, Rowe C, Lewis PS, Vasieva O, Prats N, Brillant N, Auli M, Bayliss M, Webb S, Rees JA, Kitteringham NR, Goldring CE, Park BK. 2015. Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome SCIENTIFIC REPORTS, 5 >DOI >Link
Neelima T, Taylor KMG, Saleem I, Randle L, Elsaid Z, Somavarapu S. 2013. Amphotericin polygamma glutamic acid derivatives for the delivery of amikacin to the lung Journal of Aerosol Medicine and Pulmonary Drug Delivery, 26 :A-1-A-27 >DOI
Chavan T, Taylor KMG, Saleem IY, Randle LE, Elsaid Z, Somavarapu S. 2013. O-PALMITOYL CHITOSAN-PEG MICELLES FOR AMPHOTERICIN B DELIVERY TO THE LUNG JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 26 :A249-A250 >Link
Stachulski AV, Baillie TA, Kevin Park B, Scott Obach R, Dalvie DK, Williams DP, Srivastava A, Regan SL, Antoine DJ, Goldring CEP, Chia AJL, Kitteringham NR, Randle LE, Callan H, Castrejon JL, Farrell J, Naisbitt DJ, Lennard MS. 2013. The generation, detection, and effects of reactive drug metabolites Medicinal Research Reviews, 33 :985-1080 >DOI
Kitteringham N, Abdullah A, Walsh J, Randle L, Jenkins RE, Sison R, Goldring CE, Powell H, Sanderson C, Williams S, Higgins L, Yamomoto M, Hayes J, Park BK. 2010. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. Journal of proteomics, 73 :1612-1631 >DOI
Randle LE, Sathish JG, Kitteringham NR, Macdonald I, Williams DP, Park BK. 2008. α 1-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice British Journal of Pharmacology, 153 :820-830 >DOI
Copple IM, Goldring CE, Jenkins RE, Chia AJL, Randle LE, Hayes JD, Kitteringham NR, Park BK. 2008. The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. Hepatology, 48 :1292-1301 >DOI >Link
Randle LE, Goldring CEP, Benson CA, Metcalfe PN, Kitteringham NR, Park BK, Williams DP. 2008. Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice. Toxicology, 243 :249-260 >DOI >Link
Randle LE, Sathish JG, Kitteringham NR, Macdonald I, Williams DP, Park BK. 2008. alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice. Br J Pharmacol, 153 :820-830 >DOI >Link
Williams DP, Antoine DJ, Butler PJ, Jones R, Randle L, Payne A, Howard M, Gardner I, Blagg J, Park BK. 2007. The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore. J Pharmacol Exp Ther., 3 :1208-1220
Goldring CEP, Kitteringham NR, Jenkins R, Lovatt CA, Randle LE, Abdullah A, Owen A, Liu XP, Butler PJ, Williams DP, Metcalfe P, Berens C, Hillen W, Foster B, Simpson A, McLellan L, Park BK. 2006. Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes American Journal of Physiology-Cell Physiology, 290 :C104-C115
Randle LE, Williams DP, Kitteringham NR, Richard V, Park BK, O'Brien PJ. 2006. Adrenergic modulation of chemical-induced hepatotoxicity Drug Metabolism Reviews, 38 :28-29
Randle LE, Williams DP, Goldring CEP, Park BK. 2006. Mechanisms of defence during chemical-induced hepatotoxicity Drug Metabolism Reviews, 38 :56-58
Butler PJ, Williams DP, Jones R, Randle LE, Payne A, Howard M, Gardner I, Blagg J, Smith DA, Park BK. 2006. The role of metabolism in furosemide toxicity Drug Metabolism Reviews, 38 :176-177
Goldring CEP, Kitteringham NR, Lovatt C, Jenkins R, Randle LE, Abdullah A, Owen A, Liu XP, Berens C, Hillen W, Park BK. 2005. Development of doxycycline-regulatable gene expression in hepatoma cells Toxicology, 213 :262-263
Randle LE, Greenough CL, Williams DP, Clement YN, Kitteringham NR, Elsby R, Park BK. 2004. Paracetamol-induced hepatotoxicity: Protection by alpha(1)-antagonists Toxicology, 194 :238-239
Goldring CE, Kitteringham NR, Elsby R, Randle LE, Clement YN, Williams DP, McMahon M, Hayes JD, Itoh K, Yamamoto M, Park BK. 2004. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice Hepatology, 39 :1267-1276 >Link
Butler PJ, Randle LE, Jones R, Macrae P, Blagg J, Smith DA, Williams DP, Park BK. 2004. The role of metabolism in furosemide toxicity Toxicology, 202 :98-99
O'Neill PM, Mukhtar A, Stocks PA, Randle LE, Hindley S, Ward SA, Storr RC, Bickley JF, O'Neil IA, Maggs JL, Hughes RH, Winstanley PA, Bray PG, Park BK. 2003. Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials J Med Chem, 46 :4933-4945 >DOI >Link